What is unlearn.ai?
TrialPioneer is an AI‑enabled workspace designed for upstream clinical trial design that consolidates literature search, data exploration, and scenario modeling into a single interface. It provides Scout for automated aggregation of PubMed, ClinicalTrials.
gov, and FDA drug information; Hindsight for harmonized analysis of trial and real‑world datasets; and SimLab for reproducible comparison of design scenarios. The platform integrates digital twin generators to supply AI‑generated control outcomes, enabling smaller sample sizes and increased statistical power.
Clinical development teams can use TrialPioneer to align decisions, reduce iteration cycles, and anchor assumptions to credible evidence. The solution serves sponsors, CROs, and research teams across neuroscience, immunology, metabolic disease, and other therapeutic areas.
unlearn.ai user reviews
Would you recommend unlearn.ai?
unlearn.ai's key features
-
AI-enabled unified workspace
-
Scenario builder for trial comparison
-
Automated literature search and summarization
-
Integrate real-world datasets for validation
-
Generate digital twins for control forecasts
-
Evidence-linked scenario reproducibility
-
Early-stage decision support via twins
unlearn.ai use cases
-
automate literature search and data extraction from PubMed, ClinicalTrials.gov, and FDA databases for Phase II oncology trial design, eliminating manual curation and speeding up protocol drafting
-
integrate real‑world evidence with regulatory data to create a digital twin that forecasts safety outcomes, enabling proactive risk mitigation without extensive post‑market studies
-
run scenario modeling to evaluate various enrollment and randomization strategies, dramatically reducing required sample sizes and shortening trial timelines
Who is it for?
-
Digital innovators
-
Clinical researchers
-
Pharmaceutical leaders
-
Patient advocates
-
Data scientists
